Company Overview
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugate therapies. Our pipeline includes varegacestat, a late-clinical stage GSI; IM-1021, a clinical-stage ROR1 ADC; and IM-3050, a FAP-targeted radiotherapy that recently received IND clearance. We are also advancing a broad portfolio of early stage ADCs pursuing undisclosed solid tumor targets.
Position Overview
The Learning Management System Administrator will support the administration of our Cornerstone Learning Management System and training program in a regulated pharmaceutical environment. This role will focus on system administration, compliance training support, reporting, and cross-functional coordination to ensure employees complete required training on time.
Responsibilities
Cornerstone LMS Administration
- Support day-to-day administration of the Cornerstone LMS, including user setup, course assignments, curricula, sessions, and online modules.
- Assist with configuration of learning objects, dynamic groups, automated assignments, and approval workflows.
- Troubleshoot learner issues related to access, completions, transcripts, and system navigation.
- Maintain training records to ensure accuracy, audit readiness, and compliance with regulatory requirements (GxP).
Compliance & Reporting
- Generate standard and ad hoc reports to track training completion, overdue assignments, and compliance metrics.
- Monitor required training assignments and proactively identify individuals or teams with incomplete training.
- Follow up with employees and managers to ensure timely completion of required training.
- Support internal and external audits by providing accurate training documentation and reports.
Cross-Functional Support
- Partner with HR, Quality, Compliance, Regulatory, Commercial, and department leaders to deploy and track training programs.
- Meet with stakeholders to gather information needed to load and launch new training content.
- Assist with organizing curricula and learning paths aligned with regulatory and role-based requirements.
- Provide basic guidance and support to content owners on LMS processes and best practices.
Learner Support
- Serve as a first point of contact for LMS-related questions.
- Provide clear, professional communication to employees regarding assignments and deadlines.
- Help create simple job aids or user guides to improve LMS usability.
Qualifications
- Education: Bachelor’s degree preferred.
- A minimum of 5 years of experience administering training programs. Must have at least 2 years of experience working with Cornerstone.
- Experience supporting training in a pharmaceutical, biotech, medical device, or other regulated environment.
Knowledge and Skills
- Basic understanding of LMS configuration, reporting, and user management.
- Experience generating training reports and tracking completion metrics.
- Strong attention to detail and ability to manage confidential training records.
- Experience supporting audits or regulatory inspections is a plus.
E/E/O
Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
E-Verify
Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish).
Top Skills
What We Do
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.
.png)
